Source: Cision

MetaboGen: BioGaia increases further in MetaboGen

BioGaia has decided to acquire additional shares in the associated company MetaboGen AB and is now investing SEK 11.7 million in shares in the company. BioGaia's share of the company increases from 36 percent to 62 percent, and BioGaia thereby becomes the majority shareholder in the company. In addition to the acquisition of shares, BioGaia also receives an option to acquire the remaining 38 percent in the company within a three-year period. The additional purchase price can amount to a maximum of SEK 40 million, depending on whether a number of milestones have been achieved. In December

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Sara Malcus's photo - CEO of MetaboGen

CEO

Sara Malcus

CEO Approval Rating

70/100

Read more